胰岛素联合不同口服降糖药治疗2型糖尿病的疗效比较
摘要
为观察短期联合应用口服降糖药物及胰岛素强化治疗对早期2型糖尿病患者的疗效,笔者前瞻性观察了应用甘精胰岛素联合不同口服降糖药物进行强化治疗短病程的2型糖尿病并高血糖患者的血糖变化、停药后胰岛功能改善情况及停药后患者的短期疗效。
出处
《实用医药杂志》
2009年第11期23-24,共2页
Practical Journal of Medicine & Pharmacy
参考文献6
-
1王茜,沈备,覃又文,刘超.初诊2型糖尿病患者短期强化治疗的疗效[J].中国糖尿病杂志,2008,16(5):297-298. 被引量:12
-
2刘瑞,李益明,王庆华.胰岛β细胞质量下降在糖尿病发展中的作用[J].国际内科学杂志,2008,35(5):265-268. 被引量:6
-
3Taki H, Maki T, Iso T, et al. Postmarketing study of nateglinide in Japan: treatment of medication-native patients with type 2 diabetes. Adv Ther, 2005,22(6):621.
-
4Yin J, Yang G, Cben Y. Rapid and efficient chiral separation of nateglinide and its L-enantiomer on monolithic molecularly imprinted polymers. J Chromatogr A, 2005,1090(1):68.
-
5Gefieh J, Raskin P, Jean-Louis, et al. Preserve-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus mefformin. Diabetes Care, 2005,28(9):2093.
-
6Campbell IW. Nateglinide-current and future role in the treatment of patients with type 2 diabetes mellitus. Int J Clin Fract, 2005,59(10):1218.
二级参考文献32
-
1Matthaei S, Stumvoll M, Kellerer M, et al. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev, 2000, 21(6) :585-618.
-
2Bonner-Weir S. Life and death of the pancreatic beta cells. Trends Endocrinol Metab, 2000, 11 (9) :375-378.
-
3Michelle Furtado L, Poon V, Klip A. GLUT4 activation: thoughts on possible mechanisms. Acta Physlol Stand, 2003, 178(4) :287-296.
-
4Ka]m SE, Prigeon RL, Schwartz RS, et al. Obesity, body fat distribution, insulin sensitivity and Islet beta-cell function as explanations for metabolic diversity. J Nutr, 2001, 131 (2) : 354S-360S.
-
5Lam TK, Carpentier A, Lewis GF, et al. Mechanisms of the free fatty acid-induced increase in hepatic glucose production. Am J Physiol Endocrinol Metab, 2003, 284 (5): E863-E873.
-
6Bonner-Weir S. Islet growth and development in the adult. J Mol Endocrinol, 2000, 24(3):297-302.
-
7Bonner-Weir S. Beta-cell turnover: its assessment and implications. Diabetes, 2001, 50(Suppl 1):S20-S24.
-
8Drucker DJ. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology, 2002, 122 (2): 531-544.
-
9Maedler K, Fontana A,Ris F, et al. FLIP switches Fas-mediated glucose signaling in human pancreatic bern cells from apoptosis to cell replication. Proc Natl Acad Sci U S A, 2002, 99 (12): 8236-8241.
-
10Kaiser N, Leibowitz G, Nesher R. Glucotoxicity and beta cell failure in type 2 diabetes mellitus. J Pediatr Endocrinol Metab, 2003, 16 ( 1 ) : 5-22.
共引文献14
-
1褚玉玲,蒙亚萍,宋淑琴,张志霞,王学梅.胰岛素泵对初诊2型糖尿病的疗效观察及护理体会[J].宁夏医科大学学报,2012,34(3):308-310. 被引量:1
-
2谢坤霞,肖延风,徐尔迪,尹春燕,易小青,常明.早期高脂膳食对幼鼠胰岛细胞结构和胰岛素敏感性的影响[J].中国当代儿科杂志,2010,12(9):740-743.
-
3赵通洲,张彦宁.胰岛素泵对初诊2型糖尿病患者的疗效观察[J].实用糖尿病杂志,2010,6(6):22-23.
-
4褚玉玲,蒙亚萍,张志霞,宋淑琴,王学梅.胰岛素泵对初诊2型糖尿病的疗效观察及护理[J].内蒙古中医药,2011,30(6):162-163.
-
5孙岩.胰岛素联合拜糖平治疗2型糖尿病66例疗效分析[J].中国医学创新,2012,9(3):116-117. 被引量:6
-
6孙岩.胰岛素泵强化治疗初发2型糖尿病疗效观察[J].中国当代医药,2012,19(5):38-39. 被引量:2
-
7魏宏伟.拜糖苹治疗2型糖尿病46例疗效观察[J].医学理论与实践,2012,25(24):3024-3025.
-
8孙传铎,杨峥维.胰岛素联合拜糖平治疗2型糖尿病疗效分析[J].河北医药,2013,35(7):1030-1031. 被引量:6
-
9杨滔,邱莘,莫焕娇,秋玲,陈国强.短期速效胰岛素联合长效胰岛素强化治疗对初诊2型糖尿病患者胰岛功能及氧化应激的影响[J].现代生物医学进展,2013,13(22):4341-4344. 被引量:10
-
10葛炳友,刘松涛,兰志超.甘精胰岛素联合促泌剂治疗初诊2型糖尿病患者的疗效比较[J].中国农村卫生,2013(01Z):64-64.
-
1戴建子,米健,徐静,徐峰.克拉霉素不良反应与合理用药的前瞻性观察[J].药学服务与研究,2002,2(1):41-42. 被引量:4
-
2董淑兰,陈志红,冯长虹.常规剂量头孢唑啉所致肾损害的前瞻性观察[J].临床儿科杂志,1996,14(3):198-199. 被引量:10
-
3赵学喜,蔺怀明,尚丽霞,史颖,胡兴贵.尼莫地平治疗偏头痛216例分析[J].中国实用内科杂志,2004,24(2):107-107. 被引量:15
-
4刘国珍,胡国龄,谭德明,张铮.干扰素治疗慢性乙肝的前瞻性观察及其影响因素[J].湖南医科大学学报,1998,23(4):400-402. 被引量:4
-
5张建初,张劲农,向菲,杨卫兵,李洪.高剂量盐酸左氧氟沙星注射液治疗下呼吸道感染的临床分析[J].临床内科杂志,2009,26(11):774-775.
-
6张莉蓉,王永铭.氟喹诺酮类抗菌药物不良反应的前瞻性观察[J].四川生理科学杂志,2003,25(3):141-141. 被引量:1
-
7曙光,寇双.卡马西平的疗效和副反应[J].国际中华神经精神医学杂志,2005,6(3):189-190. 被引量:1
-
8张政,甄健存,詹思延,张威,刘福珍,徐艳霞,梁雁,王佩,张慧英,李占英.左氧氟沙星注射剂不良反应与合理性用药的前瞻性观察[J].中华流行病学杂志,2001,22(6):405-407. 被引量:42
-
9戴建子,周舍典,杨威,林楚琴.联邦止咳露不良反应与合理性用药的观察[J].中国医院药学杂志,2005,25(2):190-191. 被引量:5
-
10卫英.克林霉素不良反应与合理用药观察[J].药品评价,2005,2(5):393-394. 被引量:1